Progress in the development of virus-like particle vaccines against respiratory viruses
Fu‐Shi Quan, Swarnendu Basak, Ki‐Back Chu, Sung Soo Kim, Sang‐Moo Kang
Abstract
: Previous and current preclinical and clinical studies suggest that recombinant VLP and nanoparticle vaccines are expected to be developed as promising alternative platforms against respiratory viruses in future. Therefore, continued research efforts are warranted.
Topics & Concepts
Human metapneumovirusVirologyVirusMetapneumovirusVirus-like particleBiologyMedicineRespiratory systemRespiratory tract infectionsRecombinant DNABiochemistryGeneAnatomyRespiratory viral infections researchPneumonia and Respiratory InfectionsInfluenza Virus Research Studies